Michael P Dube
Vp, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $128K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | NTLAIntellia Therapeutics, Inc. | Sell | 1,86465,022 held (−3%) | $12.43 | $23K | -8.1% |
| Jul 6SEC | NTLAIntellia Therapeutics, Inc. | Sell | 2,64166,886 held (−4%) | $16.78 | $44K | -31.9% |
| Jan 7SEC | NTLAIntellia Therapeutics, Inc. | Sell | 2,98952,277 held (−5%) | $9.21 | $28K | +24.0% |
| Oct 3SEC | NTLAIntellia Therapeutics, Inc. | Sell | 1,87155,266 held (−3%) | $17.38 | $33K | -34.3% |